Monthly U.S. Update

This topic has 9 replies, 5 voices, and was last updated 6 years, 7 months ago by Dr James.

Viewing 10 posts - 1 through 10 (of 10 total)

Author

Posts
31 January 2016 at 4:20 pm #10862
mgalbrai
- Topics: 28
- Replies: 1,298
- Total: 1,326
- Guardian Angel
@mgalbrai
March 2016

The situation continues to favorable for importation of quality, affordable HCV medications into the United States.

Several options are available, most of which require a prescription. You can get that from GP2U.com. Get your lab results scanned and ready to send before your appointment.
(Genotype, viral load, CMP, CBC)
Your PCP or specialist can order those and give you a copy. Scan them and your U.S. Prescription if you have one.

Option 1: Join the REDEMPTION clinical trials. GP2U can assist you in that regard.

Option 2: Contact a legitimate supplier directly. Incepta seems to be the simplest as far as paperwork is concerned. Email curehcvnow@gmail.com for specific contact information.

Option 3: Become a “medical tourist” This is the most expensive option both in time and money, but still pennies on the dollar compared to the cost of branded U.S. Treatments.

Option 4: Fight your insurance company for coverage. Restrictions are easing, but time and effort is still required to negotiate the process. In all likelihood, you could be “cured” by generics before ever being approved for coverage by your insurer.

Mike

Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
30 March 2016 at 7:34 pm #14651
mgalbrai
- Topics: 28
- Replies: 1,298
- Total: 1,326
- Guardian Angel
@mgalbrai
April Update:

To the best of my knowledge, the March update info is still accurate.
Although the TPP and presidential politics could change this situation at
ANY MOMENT!!
Take Australia’s recent ban on imports from Bangladesh and Egypt, for example.: A bureaucrat’s signature and a whole supply source is simply gone.
REDEMPTION, Incepta, MonkMed and Mesochem are still viable options in the U.S.
For how long?
Anyone’s guess.
M

Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
7 June 2016 at 12:01 pm #18600
mgalbrai
- Topics: 28
- Replies: 1,298
- Total: 1,326
- Guardian Angel
@mgalbrai
June 2016

The generic options in the U.S. are still viable. I would imagine Gilead is pouring money into the election campaigb coffers on both sudes of the aisle. See what they forced in Australia.
Get your medicine while you can.
m

Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
13 December 2016 at 8:45 pm #24691
mgalbrai
- Topics: 28
- Replies: 1,298
- Total: 1,326
- Guardian Angel
@mgalbrai
The importation of generic HCV medications into the US continues to be a viable alternative to exorbitantly priced branded medicines, uncertain insurance coverage and long waits for treatment.
However, the political situation is fluid. Things could change.
Don’t miss the opportunity to rid yourself of HCV in a cost-effective and timely manner.
m

Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
2 May 2017 at 10:34 pm #25951
mgalbrai
- Topics: 28
- Replies: 1,298
- Total: 1,326
- Guardian Angel
@mgalbrai
May 2017 Update:
Given the political climate in the US I would not delay accessing these lifesaving, affordable generic HCV medications.
Contact GP2U.com. Set up an appointment and get well.
m

Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
24 March 2018 at 1:15 pm #27661
mgalbrai
- Topics: 28
- Replies: 1,298
- Total: 1,326
- Guardian Angel
@mgalbrai
Hello to all visitors from the U.S. Please feel free to contact me at the email address below for answers concerning this site and how the generic treatment process works for U.S. citizens.
Mike

Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
25 March 2018 at 8:27 pm #27667
re_roll
- Topics: 8
- Replies: 120
- Total: 128
- Guardian Angel
@re_roll
mgalbrai wrote:

Hello to all visitors from the U.S. Please feel free to contact me at the email address below for answers concerning this site and how the generic treatment process works for U.S. citizens.
Mike

I second this gesture. Mike is an excellent person to contact. I recall a couple of years ago
a suggestion or two regarding a “sticky” section to highlight very important or frequently
asked questions that would benefit those who visited this website. It would be noted in red
or starred or whatever. I apologize in advance for not searching and might have missed the
answer why or there might be one.

In any case, it appears the urgency has dissipated……. Gilead is not the “bad” guy anymore,
pricing gouging comments have declined, uncaring USA GI doctors, etc. etc. etc.

Hep C is still alive and doing well here, unfortunately.

Mike is the man. Get in touch with him. Thanks , Mike, for your tireless efforts .

contracted Gen 1a in the 70’s, dx in 2007…ast 27 to 35…alt 43 to 96…vl 1.2 mil to 8.6 mil.
biopsy F-2 (2012)..pre tx results 1/23/16 ast 32, alt 46, vl 3.1 mil
tx started 2/11/16…. lab results 2/24/16 ast 18, alt 18, vl <15 IU/ml
28 days later………….lab results 3/9/16 ast 21, alt 21, vl UND
56 days later………….lab results 4/6/16 ast 20, alt 22, vl UND
139 days later………..lab results 6/29/16 ast 28, alt 30, vl UND…EOT
SVR24
27 March 2018 at 8:03 am #27687
rohcvfighter
- Topics: 50
- Replies: 338
- Total: 388
- Guardian Angel
@rohcvfighter
re_roll wrote:

In any case, it appears the urgency has dissipated……. Gilead is not the “bad” guy anymore,
pricing gouging comments have declined, uncaring USA GI doctors, etc. etc. etc.

I do not think Gilead is not “bad” anymore…. I would say they just suffer a side-effect of their high price policy and the fact that the healthcare systems do not afford to treat all patients and thus limit the access to treatments. If you look at Gilead’s financial statements for 2017 you may see:
HCV product sales, which consist of Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg), Sovaldi® (sofosbuvir 400 mg), Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg) and Vosevi® (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg), were $1.5 billion for the fourth quarter of 2017 compared to $3.2 billion for the same period in 2016 and $9.1 billion for the full year 2017 compared to $14.8 billion in 2016. The declines were across all major markets.

So a drop of sales, but it is not clear whether they treated the same number of patients as in 2016.

According to a recent news available in my country, the government contracted a number of 12 000 treatments for the year 2017 (where it is estimated that more than 600 000 people have HCV), but managed to treat only 7 000 people. The treatment is provided to F3, F4 patients and the F2 patients having certain complications. This means a huge number of patients are not eligible to receive the treatment. In addition to this only few people know they have HCV and from those who know that are sick and do not meet the criteria for getting the free treatment, the solution of generic HCV drugs via parallel importation looks as a good option. Why wait till you got sicker to meet some stupid “access to treatment criteria” when you can get treated cheaper now?

P.S. I think we are getting tired in telling over and over that governments should remove the stupid access to treatment criteria and have a closer look to generic HCV medication.

Cheers,
RHF

In fiecare an HCV ucide peste 500000 oameni.Medicamentele generice pentru hepatita C functioneaza. Nu deveni statistica! Cauta pe Google ‚Äúmedicamente generice pentru hepatita C‚Äù.
HCV kills more than 500000 people every year. HCV generic drugs work. Don’t become a statistic.
By sharing this Youtube video you might save someone‚Äôs life!
My TX: HEPCVIR-L[generic Harvoni]-India
SVR52 achieved
27 March 2018 at 7:17 pm #27705
Mar
- Topics: 3
- Replies: 287
- Total: 290
- Guardian Angel
@mar
Interesting statistics Rohcvfighter. I’m quite curious as to why Gilead’s sales numbers have dropped so dramatically in 2017, the demand is still huge. Is it possibly because insurance only treats patients with severe fibrosis, and the number of these patients still left untreated is getting smaller year after year? I wonder what the real reason is.

Making the world a better place – one patient at a time.
28 March 2018 at 3:05 am #27713
Dr James
- Topics: 264
- Replies: 1,968
- Total: 2,232
- Guardian Angel
@fixhepc
Here are the approximate sales volumes (rather than financials) – they are accurate to +/- 10%

Up until 2016Q3 Gilead published their sales volumes (to analysts) but given the revenues from the drugs are known precisely (published by all the companies in their quarterly reports) we can calculate the yields. We also know precise pricing and volumes for some of the other drugs in other markets and relative pricing.

Anyway, the bottom line is that volumes between 2015Q2 and 2016Q1 at around 160,000 treatments per quarter and have now fallen globally to 80,000 treatments per quarter.

In short, we are losing the battle to eliminate HCV.

YMMV
Author

Posts

Viewing 10 posts - 1 through 10 (of 10 total)

You must be logged in to reply to this topic.